Identification and Characterization of a Novel Major Facilitator Superfamily Efflux Pump, SA09310, Mediating Tetracycline Resistance in Staphylococcus aureus

Drug efflux systems have recently been recognized as an important mechanism of multidrug resistance in bacteria. Here, we described the identification and characterization of a novel chromosomally encoded multidrug efflux pump (SA09310) in Staphylococcus aureus. ABSTRACT Drug efflux systems have recently been recognized as an important mechanism of multidrug resistance in bacteria. Here, we described the identification and characterization of a novel chromosomally encoded multidrug efflux pump (SA09310) in Staphylococcus aureus. SA09310 is a 43-kDa protein with 12 transmembrane helices. The conserved amino acid sequence motifs of the major facilitator superfamily (MFS) were identified in the protein SA09310, which indicated that SA09310 belonged to the MFS transporters. Expression of the sa09310 gene was induced by different types of antibiotics, including aminoglycoside, tetracycline, macrolides, and chloramphenicol. An sa09310 gene knockout mutant (Δsa09310) was constructed, and its susceptibility to 30 different antibiotics was evaluated. The Δsa09310 mutant exhibited increased sensitivity to tetracycline and doxycycline, with 64-fold- and 8-fold-decreased MICs, respectively. The mechanism of SA09310 mediation of tetracycline resistance was demonstrated by its ability to extrude intracellular tetracycline from within the cells into the environment. The efflux activity of SA09310 was further confirmed by ethidium bromide (EtBr) accumulation and efflux assays. In addition, the efflux activity of SA09310 was observed to be blocked by the known efflux pump inhibitor carbonyl cyanide chlorophenylhydrazone (CCCP), which provided direct evidence that suggested the H+-dependent activity of the SA09310 efflux pump. The conservation of SA09310 homologs in Staphylococcus indicated the universal function of these SA09310-like protein clusters. In conclusion, the function-unknown protein SA09310 has been identified and characterized as a tetracycline efflux pump mediating tetracycline resistance in S. aureus.

[1]  Chao Liu,et al.  Dissemination of the mobilised RND efflux pump gene cluster tmexCD-toprJ among Klebsiella pneumoniae. , 2022, The Lancet. Microbe.

[2]  Daiyu Li,et al.  Identification and Application of a Panel of Constitutive Promoters for Gene Overexpression in Staphylococcus aureus , 2022, Frontiers in Microbiology.

[3]  Melissa H. Brown,et al.  Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition , 2021, Antibiotics.

[4]  R. H. Mallappa,et al.  Antibiotic Resistance Crisis: An Update on Antagonistic Interactions between Probiotics and Methicillin-Resistant Staphylococcus aureus (MRSA) , 2021, Current Microbiology.

[5]  M. Ojha,et al.  Functional and Structural Roles of the Major Facilitator Superfamily Bacterial Multidrug Efflux Pumps , 2020, Microorganisms.

[6]  B. Sharma-Kuinkel,et al.  Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research , 2019, Nature Reviews Microbiology.

[7]  P. Ruggerone,et al.  Molecular Rationale behind the Differential Substrate Specificity of Bacterial RND Multi-Drug Transporters , 2017, Scientific Reports.

[8]  T. Grossman.  Tetracycline Antibiotics and Resistance. , 2016, Cold Spring Harbor perspectives in medicine.

[9]  S. Peacock,et al.  Mechanisms of Methicillin Resistance in Staphylococcus aureus. , 2015, Annual review of biochemistry.

[10]  G. Kaatz,et al.  Analyses of Multidrug Efflux Pump-Like Proteins Encoded on the Staphylococcus aureus Chromosome , 2014, Antimicrobial Agents and Chemotherapy.

[11]  Q. C. Truong-Bolduc,et al.  Regulation of Expression of abcA and Its Response to Environmental Conditions , 2014, Journal of bacteriology.

[12]  G. Kaatz,et al.  Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics. , 2013, Future microbiology.

[13]  L. Amaral,et al.  Send Orders of Reprints at Reprints@benthamscience.net Multidrug Efflux Pumps in Staphylococcus Aureus: an Update , 2022 .

[14]  J. Handzlik,et al.  Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus , 2013, Antibiotics.

[15]  C. McDevitt,et al.  The role of ATP-binding cassette transporters in bacterial pathogenicity , 2012, Protoplasma.

[16]  R. Wallace,,et al.  Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes , 2011 .

[17]  T. Vernet,et al.  Penicillin-binding proteins and beta-lactam resistance. , 2008, FEMS microbiology reviews.

[18]  S. Levy,et al.  Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.

[19]  P. Bradford,et al.  A Novel MATE Family Efflux Pump Contributes to the Reduced Susceptibility of Laboratory-Derived Staphylococcus aureus Mutants to Tigecycline , 2005, Antimicrobial Agents and Chemotherapy.

[20]  G. Kaatz,et al.  Multidrug Resistance in Staphylococcus aureus Due to Overexpression of a Novel Multidrug and Toxin Extrusion (MATE) Transport Protein , 2005, Antimicrobial Agents and Chemotherapy.

[21]  Q. C. Truong-Bolduc,et al.  MgrA Is a Multiple Regulator of Two New Efflux Pumps in Staphylococcus aureus , 2005, Journal of bacteriology.

[22]  A. Walmsley,et al.  The structure and function of drug pumps: an update. , 2003, Trends in microbiology.

[23]  M. Schumacher,et al.  Structural mechanisms of multidrug recognition and regulation by bacterial multidrug transcription factors , 2002, Molecular Microbiology.

[24]  K. Poole,et al.  The MexR Repressor of the mexAB-oprM Multidrug Efflux Operon in Pseudomonas aeruginosa: Characterization of Mutations Compromising Activity , 2002, Journal of bacteriology.

[25]  K. Poole.  Mechanisms of bacterial biocide and antibiotic resistance , 2002, Journal of applied microbiology.

[26]  A Yonath,et al.  Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3 , 2001, The EMBO journal.

[27]  V. Ramakrishnan,et al.  The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit , 2000, Cell.

[28]  A. Matin,et al.  The EmrR Protein Represses the Escherichia coli emrRAB Multidrug Resistance Operon by Directly Binding to Its Promoter Region , 2000, Antimicrobial Agents and Chemotherapy.

[29]  I. Paulsen,et al.  QacR Is a Repressor Protein That Regulates Expression of theStaphylococcus aureus Multidrug Efflux Pump QacA* , 1998, The Journal of Biological Chemistry.

[30]  I. Paulsen,et al.  Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.

[31]  R. Brückner.  Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. , 1997, FEMS microbiology letters.

[32]  N. Fujita,et al.  Purification and regulatory properties of MarA protein, a transcriptional activator of Escherichia coli multiple antibiotic and superoxide resistance promoters , 1995, Journal of bacteriology.

[33]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[34]  J. Griffith,et al.  Nucleotide and deduced protein sequences of the class D tetracycline resistance determinant: relationship to other antimicrobial transport proteins , 1993, Antimicrobial Agents and Chemotherapy.

[35]  I. Paulsen,et al.  Membrane transport proteins: implications of sequence comparisons. , 1992, Current opinion in cell biology.

[36]  S. Schenk,et al.  Improved method for electroporation of Staphylococcus aureus. , 1992, FEMS microbiology letters.

[37]  T. Littlejohn,et al.  Efflux‐mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline‐ and sugar‐transport proteins , 1990, Molecular microbiology.

[38]  M. Coyle,et al.  Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test , 1979, Journal of clinical microbiology.

[39]  I. Maxwell.  Partial removal of bound transfer RNA from polysomes engaged in protein synthesis in vitro after addition of tetracycline. , 1967, Biochimica et biophysica acta.